Profile data is unavailable for this security.
About the company
Guangxi Wuzhou Zhongheng Group Co Ltd is a China-based company mainly engaged in pharmaceutical business. The Company conducts its businesses through four segments. The Pharmaceutical segment is mainly engaged in the production and sale of medicines, and products cover cardiovascular and cerebrovascular, specialty, musculoskeletal, gynecological diseases, respiratory system, anti-infection and other fields. The Food segment is mainly engaged in the production and sale of Chinese herbal jelly products, red bean Shaoxiancao and other products. The Real Estate segment is mainly engaged in the operation and development of real estate. The Household Chemicals segment is mainly engaged in the production and sale of daily chemical products. The Company mainly conducts its businesses in domestic and foreign markets.
- Revenue in CNY (TTM)2.29bn
- Net income in CNY-363.56m
- Incorporated1993
- Employees2.97k
- LocationGuangxi Wuzhou Zhongheng Group Co LtdNo. 1Industrial Avenue, Industrial ParkWUZHOU 543000ChinaCHN
- Phone+86 7 712742275
- Fax+86 7 743939053
- Websitehttps://www.wz-zhongheng.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cisen Pharmaceutical Co Ltd | 3.56bn | 492.80m | 7.92bn | 3.30k | 16.21 | 1.29 | -- | 2.23 | 1.08 | 1.08 | 7.84 | 13.59 | 0.472 | 2.10 | 5.34 | 1,079,074.00 | 6.58 | 6.51 | 8.12 | 8.07 | 53.70 | 55.92 | 13.94 | 10.84 | 3.48 | -- | 0.0069 | 37.16 | -10.77 | -0.6464 | -2.38 | -0.2215 | -0.3051 | 10.42 |
| Heilongjiang ZBD Pharmaceutical Co Ltd | 1.60bn | -332.62m | 7.94bn | 2.35k | -- | 1.08 | -- | 4.95 | -0.3545 | -0.3545 | 1.70 | 7.75 | 0.1303 | 0.6358 | 0.4977 | 679,399.90 | -2.74 | 3.29 | -3.80 | 4.46 | 44.16 | 37.24 | -21.03 | 10.59 | 1.33 | -1.45 | 0.3114 | 24.43 | -13.90 | -3.87 | -7.30 | 1.41 | 1.13 | -7.12 |
| China Animal Husbandry Industry Co., Ltd | 6.28bn | 214.44m | 8.10bn | 4.30k | 37.19 | 1.39 | -- | 1.27 | 0.21 | 0.21 | 6.15 | 5.60 | 0.6863 | 5.30 | 4.19 | 1,461,064.00 | 2.32 | 5.25 | 3.37 | 7.48 | 15.59 | 22.15 | 3.38 | 7.31 | 1.62 | -- | 0.1625 | 31.16 | 11.30 | 7.79 | -82.41 | -22.24 | -0.0699 | -21.83 |
| Zhejiang Ausun Pharmaceutical Co Ltd | 751.12m | 184.84m | 8.18bn | 1.22k | 44.04 | 3.49 | -- | 10.91 | 0.2241 | 0.2241 | 0.8963 | 2.83 | 0.2472 | 0.9248 | 3.00 | 616,180.10 | 6.08 | 8.91 | 7.77 | 12.10 | 51.51 | 53.44 | 24.61 | 27.68 | 2.17 | -- | 0.1383 | 27.35 | -2.63 | 20.90 | -18.55 | 29.68 | 17.53 | 43.79 |
| Sichuan Huiyu Pharmaceutical Co Ltd | 984.29m | 47.23m | 8.27bn | 1.38k | 175.96 | 2.23 | -- | 8.44 | 0.1115 | 0.1115 | 2.32 | 8.81 | 0.1983 | 0.9536 | 14.36 | 712,220.30 | 0.8073 | 8.62 | 1.04 | 10.46 | 80.54 | 88.41 | 4.07 | 22.26 | 2.63 | -- | 0.1185 | 24.48 | 18.05 | 9.13 | 132.78 | 12.96 | 3.11 | -- |
| Guangxi Wuzhou Zhongheng Group Co Ltd | 2.29bn | -363.56m | 8.28bn | 2.97k | -- | 1.42 | -- | 3.58 | -0.1112 | -0.1112 | 0.7189 | 1.82 | 0.204 | 2.09 | 3.30 | 771,487.60 | -4.90 | -0.1745 | -7.79 | -0.2739 | 34.13 | 64.36 | -24.05 | -0.6631 | 2.01 | -5.26 | 0.2563 | 69.54 | -26.67 | -9.85 | -547.14 | -- | 4.41 | -- |
| Changchun BCHT Biotechnology Co | 677.51m | -170.53m | 8.31bn | 1.27k | -- | 2.10 | -- | 12.27 | -0.4124 | -0.4124 | 1.64 | 9.57 | 0.1288 | 0.7183 | 0.4756 | 531,801.10 | -3.24 | 8.14 | -4.12 | 10.19 | 77.22 | 85.58 | -25.17 | 23.29 | 1.20 | -8.89 | 0.0696 | 14.91 | -32.64 | 4.73 | -53.67 | 0.9824 | 33.40 | -- |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 3.13bn | 234.36m | 8.39bn | 6.13k | 35.71 | 1.77 | -- | 2.67 | 0.4136 | 0.4136 | 5.50 | 8.33 | 0.459 | 2.03 | 5.49 | 510,570.90 | 3.29 | 5.72 | 4.42 | 8.14 | 67.90 | 72.85 | 7.18 | 9.42 | 1.73 | 47.38 | 0.0006 | 18.39 | -19.86 | -3.11 | -15.58 | -5.02 | -0.5518 | -- |
| Nanjing Vazyme Biotech Co Ltd | 1.34bn | -29.64m | 8.41bn | 2.87k | -- | 2.17 | -- | 6.21 | -0.0817 | -0.0817 | 3.98 | 9.66 | 0.2715 | 1.10 | 2.75 | 468,919.20 | -0.6649 | 9.69 | -0.8034 | 11.88 | 68.89 | 69.81 | -2.45 | 20.70 | 3.34 | -- | 0.1832 | 35.88 | 7.15 | 38.71 | 74.50 | -- | 30.38 | -- |
Data as of Feb 10 2026. Currency figures normalised to Guangxi Wuzhou Zhongheng Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 29 Jul 2025 | 25.30m | 0.74% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 14.43m | 0.42% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 12.68m | 0.37% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 11.56m | 0.34% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 8.86m | 0.26% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 4.91m | 0.14% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 4.62m | 0.13% |
| Dimensional Fund Advisors LPas of 30 Nov 2025 | 4.37m | 0.13% |
| Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 2025 | 3.35m | 0.10% |
| Vanguard Asset Management Ltd.as of 31 Dec 2025 | 1.50m | 0.04% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
